(Report ID: 45010) Many drug interactions and side effects can not be detected until the drugs have been used by millions of people, and for a long time. Large, long-term drug safety studies are ideal to discover these real-world drug outcomes. For the first time, eHealthMe enables health professionals and patients to conduct these studies for their drugs. Click here to check your drugs now, in a whole new way. As of Nov, 21, 2008, eHealthMe analyzes 10,180,646 drug interactions and side effects of 21,667 FDA-approved drugs from 1977 to the present. Results on Nov, 21, 2008: 112 relevant incidents
Note:
- The incidents can not include all actual occurrences
- Data of 2008 is not complete
DISCLAIMER: All adverse drug reaction material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk. Basic information:
| Report ID | Date of submission | Patient age | Patient gender |
| 45010 | Feb, 6, 2006 | Not specified | Female |
List of drugs the patient takes:
List of drug interactions, adverse side effects / events the patient has:
| Name |
Hepatic Necrosis |
Hepatitis |
Results from eHealthMe: 112 relevent incidents1) Comparison with the patient's adverse outcomes:
| Name | Count (% of total reports) |
Hepatic Necrosis | 3 (2.68%) |
Hepatitis | 9 (8.04%) |
2) Top drug interactions, adverse side effects reported for the past 12 months:Death: 0 Cancer: 0
| Name | Count (% of total reports) |
1 | Aspartate Aminotransferase Increased | 2 (33.33%) |
2 | Blood Cholesterol Increased | 2 (33.33%) |
3 | Alanine Aminotransferase Increased | 2 (33.33%) |
4 | Type 2 Diabetes Mellitus | 2 (33.33%) |
5 | Gallbladder Operation | 2 (33.33%) |
6 | Sensation Of Foreign Body | 2 (33.33%) |
7 | Hepatic Failure | 1 (16.67%) |
8 | Hyperhidrosis | 1 (16.67%) |
9 | Heart Injury | 1 (16.67%) |
10 | Hepatitis Toxic | 1 (16.67%) |
3) Top co-used drugs drugs reported for the past 12 months:
| Name | Count |
1 | Nexium | 3 |
2 | Potassium Chloride | 3 |
3 | Nystatin | 3 |
4 | Duoneb | 2 |
5 | Zetia | 2 |
6 | Humalog | 2 |
7 | Ursodiol | 2 |
8 | Zoloft | 2 |
9 | Meclizine | 2 |
10 | Cymbalta | 2 |
4) Top drug interactions, adverse side effects reported of all time:Death: 3 (2.68% of total reports) Cancer: 0
| Name | Count (% of total reports) |
1 | Alanine Aminotransferase Increased | 31 (27.68%) |
2 | Aspartate Aminotransferase Increased | 31 (27.68%) |
3 | Nausea | 20 (17.86%) |
4 | Pyrexia | 19 (16.96%) |
5 | Vision Blurred | 18 (16.07%) |
6 | Dizziness | 17 (15.18%) |
7 | Blood Alkaline Phosphatase Increased | 16 (14.29%) |
8 | Liver Function Test Abnormal | 13 (11.61%) |
9 | Dyspnoea | 12 (10.71%) |
10 | Asthenia | 12 (10.71%) |
5) Top co-used drugs drugs reported of all time:
| Name | Count |
1 | Lasix | 14 |
2 | Aspirin | 13 |
3 | Furosemide | 11 |
4 | Potassium Chloride | 11 |
5 | Lantus | 11 |
6 | Ambien | 9 |
7 | Nexium | 8 |
8 | Albuterol | 7 |
9 | Lipitor | 7 |
10 | Neurontin | 7 |
Want to have a risk analysis report like this for your drugs? Click here. ADVERTISEMENT
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Recent drug risk analysis reports:
Cymbalta (Lilly) - EQ 20MG BASE for Depression (Nov, 21, 2008)
|
Vicodin Es (Abbott) - 750MG;7.5MG for Toothaches (Nov, 21, 2008)
|
Vicodin Es (Abbott) - 750MG;7.5MG for Toothaches (Nov, 21, 2008)
|
Lyrica (Pfizer) - 100MG for Back Pain - Low (Nov, 21, 2008)
|
Sodium Bicarbonate (Hospira) - 0.9MEQ... for Heartburn (Nov, 21, 2008)
|
Side effects comparison of Lipitor (Pfizer) - EQ 20MG BASE (Nov, 21, 2008)
|
Lipitor (Pfizer) - EQ 20MG BASE for Cholesterol (Nov, 21, 2008)
|
Lipitor (Pfizer) - EQ 20MG BASE for Cholesterol (Nov, 21, 2008)
|
Digoxin (Roxane) - 0.05MG/ML for Heart Condition (Nov, 21, 2008)
|
Digoxin (Roxane) - 0.05MG/ML for Heart Condition (Nov, 21, 2008)
|
|
|
|
 |
|
How to use the report?
Bring a copy of this report to a doctor's appointment to ensure drug risks are fully discussed and understood, in the process of risk and benefit assessment.
|
 |
|
ADVERTISEMENT
|
|